19/11/2025
The Plasma Protein Therapeutics Association (PPTA) welcomes the recent position paper of the Hellenic Association of Pharmaceutical Companies (SFEE) on establishing a data-informed, European-aligned framework for plasma collection in Greece. SFEE’s proposals are an important step toward ensuring that national policies reflect patient needs and support sustainable, resilient, and safe health care systems.
As the global trade association representing leading manufacturers of plasma-derived medicines and plasma collectors, PPTA stands ready to collaborate with SFEE and all relevant stakeholders on a comprehensive national framework for plasma-derived medicinal products (PDMPs), including plasma collection. A clear, evidence-based framework is essential to ensure that all plasma collection- whether public or private - operates to the same high standards of safety and quality.
Drawing on its long-standing international and technical expertise in plasma collection and fractionation, PPTA supports efforts to build national frameworks consistent with Europe’s goal of open strategic autonomy, safeguarding supply security and uninterrupted patient access while upholding the highest standards of donor and patient safety, product quality, and ethical donation practices. Experience from other European countries shows that well-regulated private and public plasma collection can safely coexist and together contribute to a more secure supply of PDMPs.
Marilena Vrana, Vice President of Public Affairs& EU Operations at the Plasma Protein Therapeutics Association (PPTA Europe), states the following:
“PPTA welcomes and supports SFEE’s efforts to highlight and address the pressing challenge of insufficient plasma collection in Europe. The alignment between our organizations marks a significant step forward, underscoring the need for a data-informed, effective framework that strengthens Europe’s plasma autonomy, guarantees robust safety standards across all types of plasma collection, and bolsters the resilience of the Greek health care system.”
PPTA and its members share a common vision: to address the growing and unmet needs of patients who depend on plasma-derived therapies and to strengthen Europe’s capacity to ensure adequate, reliable, and safe access to lifesaving PDMPs. PPTA remains committed to constructive dialogue and to supporting initiatives that enhance plasma collection in both public and private settings, protect donor and patient well-being, and reinforce the resilience of health care systems in Greece and across Europe.
Read the statement in Greek.